SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Anaxagoras who wrote (1699)1/14/1998 9:59:00 PM
From: Bill Wexler  Read Replies (3) of 7041
 
<<If this were true, then don't you think it would have been obvious to SGP that the product was a joke?>>

It wasn't "obvious" that it was a joke when Podolski made this deal. Like I said previously, the in-house scientists did not review the drug in any way including its formulation. You may find this hard to believe, but it is absolutely true. Schering-plough's past history with these sort of outside investments has been less than stellar. Lot's of smart institutional investors put millions into Bre-x. Don't think for a second that a Pharma can't be conned - or that there isn't more going on than meets the eye.

Counting on the Schering deal to somehow "validate" this company's bogus science is a terrible mistake - don't be misled. As far as trading this from the long side - I hope you make money, I really do. There is always the possibility that I'm terribly mistaken - but so far, the evidence only keeps getting more compelling that this is a full-fledged scam.

Like I said in my previous post...stay tuned.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext